Kalvista Pharmaceuticals Inc (KALV)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 04/30
| 03-2014 | 01-2014 | 12-2013 | 04-2013 | 01-2013 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 0 | N/A | 9,780 | N/A | 0 |
| Other current assets | 0 | 0 | 130 | 120 | 0 |
| TOTAL | $0 | $N/A | $9,910 | $120 | $0 |
| Non-Current Assets | |||||
| PPE Net | N/A | 70 | 510 | N/A | N/A |
| Other Non-Current Assets | 0 | 0 | 120 | 0 | 0 |
| TOTAL | $N/A | $70 | $630 | $N/A | $N/A |
| Total Assets | $0 | $70 | $10,100 | $120 | $0 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 0 | N/A | 3,060 | N/A | 0 |
| Accounts payable and accrued liabilities | 0 | 0 | 460 | 0 | 0 |
| Accrued Expenses | 0 | N/A | 390 | N/A | 0 |
| Other current liabilities | 0 | N/A | 20 | 20 | 0 |
| TOTAL | $0 | $N/A | $3,950 | $20 | $0 |
| Non-Current Liabilities | |||||
| Other Non-Current Liabilities | 0 | 0 | 180 | 184 | 0 |
| TOTAL | $N/A | $N/A | $300 | $184 | $N/A |
| Total Liabilities | $0 | $N/A | $4,250 | $204 | $0 |
| Shareholders' Equity | |||||
| Retained earnings | 0 | N/A | -34,410 | N/A | 0 |
| Other shareholders' equity | 0 | 0 | 39,550 | 39,556 | 0 |
| TOTAL | $0 | $N/A | $5,840 | $39,556 | $0 |
| Total Liabilities And Equity | $0 | $0 | $10,090 | $39,760 | $0 |